332.00
-23.00
(-6.48%)
At close: January 21 at 11:25:57 AM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 11 |
| Avg. Estimate | 181.03M | 185.55M | 758.62M | 772.21M |
| Low Estimate | 176.9M | 180M | 754.7M | 729.5M |
| High Estimate | 183.31M | 201M | 761.16M | 840.78M |
| Year Ago Sales | 183.93M | 190.94M | 689.14M | 758.62M |
| Sales Growth (year/est) | -1.58% | -2.82% | 10.08% | 1.79% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UPWK.MX | -- | -- | -- | -- |
| S&P 500 | 9.34% | 11.29% | 14.06% | 13.55% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 1/17/2025 |
| Maintains | Jefferies: Buy to Buy | 1/6/2025 |
| Maintains | UBS: Neutral to Neutral | 12/4/2024 |
| Maintains | Citigroup: Neutral to Neutral | 11/29/2024 |
| Maintains | BTIG: Buy to Buy | 11/7/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/7/2024 |